Anatara Lifesciences Stock Cash Per Share
| ANR Stock | 0.01 0.0005 7.14% |
Anatara Lifesciences fundamentals help investors to digest information that contributes to Anatara Lifesciences' financial success or failures. It also enables traders to predict the movement of Anatara Stock. The fundamental analysis module provides a way to measure Anatara Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Anatara Lifesciences stock.
Anatara |
Anatara Lifesciences Company Cash Per Share Analysis
Anatara Lifesciences' Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
| Competition |
In accordance with the recently published financial statements, Anatara Lifesciences has a Cash Per Share of 0.0 times. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all Australia stocks average (which is currently at 0.0).
Did you try this?
Run Portfolio Comparator Now
Portfolio ComparatorCompare the composition, asset allocations and performance of any two portfolios in your account |
| All Next | Launch Module |
Anatara Fundamentals
| Return On Equity | -1.47 | ||||
| Return On Asset | -0.76 | ||||
| Operating Margin | (2.23) % | ||||
| Current Valuation | 391.96 K | ||||
| Shares Outstanding | 213.38 M | ||||
| Shares Owned By Insiders | 40.43 % | ||||
| Shares Owned By Institutions | 13.68 % | ||||
| Price To Book | 1.10 X | ||||
| Price To Sales | 5.96 X | ||||
| Revenue | 250.51 K | ||||
| Gross Profit | (1.07 M) | ||||
| EBITDA | (1.46 M) | ||||
| Net Income | (1.45 M) | ||||
| Total Debt | 306.85 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (1.25 M) | ||||
| Earnings Per Share | (0.01) X | ||||
| Target Price | 1.79 | ||||
| Beta | 0.69 | ||||
| Market Capitalization | 1.49 M | ||||
| Total Asset | 1.67 M | ||||
| Retained Earnings | (22.09 M) | ||||
| Working Capital | 1.37 M | ||||
| Net Asset | 1.67 M |
About Anatara Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Anatara Lifesciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Anatara Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Anatara Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Anatara Stock Analysis
When running Anatara Lifesciences' price analysis, check to measure Anatara Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anatara Lifesciences is operating at the current time. Most of Anatara Lifesciences' value examination focuses on studying past and present price action to predict the probability of Anatara Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anatara Lifesciences' price. Additionally, you may evaluate how the addition of Anatara Lifesciences to your portfolios can decrease your overall portfolio volatility.